SCH772984 TFA |
| Katalog-Nr.GC15044 |
ERK1/2 inhibitor
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
Product has been cited by 1 publications
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
SCH772984 TFA
| Cas No. | SDF | ||
| Chemical Name | (S)-1-(2-oxo-2-(4-(4-(pyrimidin-2-yl)phenyl)piperazin-1-yl)ethyl)-N-(3-(pyridin-4-yl)-2H-indazol-5-yl)pyrrolidine-3-carboxamide 2,2,2-trifluoroacetate | ||
| Canonical SMILES | O=C([C@@H]1CN(CC(N2CCN(C3=CC=C(C4=NC=CC=N4)C=C3)CC2)=O)CC1)NC5=CC6=C(C7=CC=NC=C7)NN=C6C=C5.FC(F)(C(O)=O)F | ||
| Formula | C35H34F3N9O4 | M.Wt | 701.7 |
| Löslichkeit | ≥ 26.1mg/mL in Water with gentle warming | Storage | Store at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
Complete Stock Solution Preparation Table
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 1.4251 mL | 7.1256 mL | 14.2511 mL |
| 5 mM | 0.285 mL | 1.4251 mL | 2.8502 mL |
| 10 mM | 0.1425 mL | 0.7126 mL | 1.4251 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GC39813 MC-DM1
- GC41965 17-phenyl trinor Prostaglandin E2
- GC43514 D-myo-Inositol-1,3,4,5,6-pentaphosphate (ammonium salt)
- GC38811 Mcl1-IN-8
- GC12943 STING agonist-1
- GC40037 Linoleoyl-L-carnitine (chloride)
- GC17611 Gadodiamide hydrate
- GC61099 m-Tolylacetic acid
- GC45801 Hesperetin-13C-d3
- GC39397 Lp-PLA2-IN-3
- GC10964 Estradiol 17-(β-D-Glucuronide) (sodium salt)
- GC45500 Liproxstatin-1 analog
- GC40455 17(R)-HETE
- GC60982 LEI-401
- GC14150 DPNI-caged-GABA
- GC44290 NAADP (sodium salt)
- GC44101 Lyso-Globotriaosylceramide (d18:1)
Bewertungen
Average Rating: 5 ★★★★★ (Based on Reviews and 39 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *